Does PEMBROLIZUMAB Cause White blood cell count increased? 162 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 162 reports of White blood cell count increased have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.2% of all adverse event reports for PEMBROLIZUMAB.
162
Reports of White blood cell count increased with PEMBROLIZUMAB
0.2%
of all PEMBROLIZUMAB reports
25
Deaths
88
Hospitalizations
How Dangerous Is White blood cell count increased From PEMBROLIZUMAB?
Of the 162 reports, 25 (15.4%) resulted in death, 88 (54.3%) required hospitalization, and 12 (7.4%) were considered life-threatening.
Is White blood cell count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 162 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause White blood cell count increased?
CLOZAPINE (2,988)
ADALIMUMAB (1,710)
RUXOLITINIB (1,529)
IBRUTINIB (1,390)
RITUXIMAB (886)
METHOTREXATE (741)
PREDNISONE (716)
ETANERCEPT (615)
IMATINIB (520)
TOCILIZUMAB (478)
Which PEMBROLIZUMAB Alternatives Have Lower White blood cell count increased Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G